Page last updated: 2024-10-22

tyrphostin ag 1024 and Brain Neoplasms

tyrphostin ag 1024 has been researched along with Brain Neoplasms in 2 studies

tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steinbach, JP1
Eisenmann, C1
Klumpp, A1
Weller, M1
Carapancea, M1
Cosaceanu, D1
Budiu, R1
Kwiecinska, A1
Tataranu, L1
Ciubotaru, V1
Alexandru, O1
Banita, M1
Pisoschi, C1
Bäcklund, ML1
Lewensohn, R1
Dricu, A1

Other Studies

2 other studies available for tyrphostin ag 1024 and Brain Neoplasms

ArticleYear
Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis.
    Biochemical and biophysical research communications, 2004, Aug-27, Volume: 321, Issue:3

    Topics: Apoptosis; Brain Neoplasms; Caspase 8; Caspases; Cell Line, Tumor; Enzyme Inhibitors; ErbB Receptors

2004
Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.
    Journal of neuro-oncology, 2007, Volume: 85, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Proliferatio

2007